Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Biomarkers of Pre-COPD Lung Function Trajectories in Middle Age: A Prospective Study From 1st to 6th Decade.
Respirology (Carlton, Vic.)·2026
Same author
Moving to better COPD care-changes to and challenges for GOLD.
American journal of respiratory and critical care medicine·2026
Same author
The Potential Role of DPP-1 Inhibitors in Chronic Obstructive Pulmonary Disease.
Archivos de bronconeumologia·2026
Related Experiment Video
Updated: May 7, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Immune response in chronic obstructive pulmonary disease.
Rosa Faner1, Tamara Cruz, Alvar Agusti
1FISIB, CIBER Enfermedades Respiratorias (CIBERES), Mallorca, Spain.
Expert Review of Clinical Immunology
|September 28, 2013
Summary
Chronic obstructive pulmonary disease (COPD) may involve an autoimmune component. Genetic factors and an enhanced inflammatory response in susceptible smokers contribute to COPD pathogenesis, persisting even after smoking cessation.
Area of Science:
- Pulmonary Medicine
- Immunology
- Genetics
Background:
- Chronic obstructive pulmonary disease (COPD) is a significant global health issue with high prevalence and costs.
- Tobacco smoke is the primary risk factor, but genetic susceptibility influences disease development.
- Susceptible smokers show heightened and persistent lung inflammation compared to resistant smokers.
Purpose of the Study:
- To review COPD pathobiology and examine evidence for autoimmunity in its pathogenesis.
- To propose a pathogenic hypothesis for COPD development in smokers.
- To discuss potential diagnostic and therapeutic implications of autoimmunity in COPD.
Main Methods:
- Literature review of COPD pathobiology.
- Analysis of scientific evidence for autoimmune involvement.
- Formulation of a multi-step pathogenic hypothesis.
- Discussion of clinical implications.
Main Results:
- Genetic background plays a crucial role in COPD susceptibility.
- Enhanced and persistent lung inflammation in susceptible smokers suggests potential autoimmune mechanisms.
- A three-step hypothesis is proposed for the transition from smoking to COPD.
Conclusions:
- Autoimmunity may be a key factor in the pathogenesis of COPD for certain individuals.
- Understanding autoimmune contributions could lead to novel diagnostic and treatment strategies for COPD.
- Further research is warranted to validate the role of autoimmunity in COPD.